|
Quotes & Info
|
| GLIF.OB > SEC Filings for GLIF.OB > Form 8-K on 14-Mar-2008 | All Recent SEC Filings |
14-Mar-2008
Change in Directors or Principal Officers
On March 11, 2008, Grant Life Sciences, Inc. (the "Company"), announced the resignation of Doyle Judd, its Chief Financial Officer, effective immediately.
|
|